Celularity Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Celularity Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $108.00K.
- Celularity Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $4.00K, a 98.72% decline year-over-year.
- Celularity Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-03-31 was $300.00K, a 1328.57% increase year-over-year.
- Celularity Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $399.00K, a 90.91% increase year-over-year.
- Celularity Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $108.00K, a 86.21% increase from fiscal 2024.
- Celularity Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $58.00K, a 80.92% decline from fiscal 2023.
- Celularity Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $304.00K, a 67.93% decline from fiscal 2022.
- Celularity Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $948.00K, a 381.22% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $108.00K 10-K · filed 2026-04-30 | |
| 2025-09-30 | $108.00K 10-Q · filed 2025-11-14 | |
| 2024-12-31 | $58.00K 10-K · filed 2026-04-30 | |
| 2023-12-31 | $304.00K 10-K · filed 2025-05-08 | |
| 2023-06-30 | $4.00K 10-Q · filed 2024-12-06 | |
| 2023-03-31 | $300.00K 10-Q · filed 2024-12-06 | |
| 2022-12-31 | $948.00K 10-K · filed 2024-07-30 | |
| 2022-09-30 | $399.00K 10-Q · filed 2024-01-03 | |
| 2022-06-30 | $313.00K 10-Q · filed 2024-01-03 | |
| 2022-03-31 | $21.00K 10-Q · filed 2024-01-03 | |
| 2021-12-31 | $197.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $209.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $14.00K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $138.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $37.00K 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $15.00K 10-Q · filed 2021-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |